bioRxivMicrobiologyPreprint
Nasal environment potentiates the pathogenicity of Bordetella pertussis
Dacine Osmani Raik, Anne‐Sophie DebrieiD, Rudy AntoineiD, Stéphanie Slupek, Maud DenyiD, Sophie LecheriD, Anne‐Sophie LacosteiD, Jean‐Michel SaliouiD, Jimmy VandeliD, Estelle Chatelain, Mamadou Dia Sow, Nathalie MielcarekiD, Loïc CoutteiD
Abstract
Pertussis remains a major health concern, as acellular vaccines fail to prevent nasal infection and transmission. The nasal cavity is the primary niche for Bordetella pertussis colonization, but how this particular environment shapes bacterial pathogenicity remains poorly understood. Here we developed bacterial culture conditions that replicate the nasal environment, combining nasal-fluid-like transition metals concentrations with nasal cavity temperature. Using complementary transcriptomic and proteomic approaches, Dual RNA-sequencing, and in vitro and in vivo infection models, we assessed their impact on host-pathogen interactions. Nasal-like conditions reprogram B. pertussis into a state of increased virulence, conferring functional advantages for efficient bacterium-cell interactions and inducing physiological remodeling of human nasal epithelial cells. Finally, we showed that nasal preconditioning promotes efficient early B. pertussis colonization in mice. Altogether, these findings identify the nasal cavity as an instructive niche priming B. pertussis for efficient upper respiratory tract colonization following airborne transmission.
- organism: human
- assay: proteomics
- assay: bulk RNA-seq
- research focus: host-pathogen & immune response
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Limited response of primary nasal epithelial cells to Bordetella pertussis infection and the effector protein BteA
Martin Zmuda, Barbora Pravdova, … Jana Kamanová·bioRxiv·Feb 3, 2025
- Use of Mucosally Administered Outer Membrane Vesicles Derived from Bordetella pertussis to Diminish Nasal Bacterial Colonization
E. Rudi, M. E. Gaillard, … D. Hozbor·bioRxiv·Mar 11, 2024
- C-terminal domain of the filamentous hemagglutinin FhaB is crucial for interaction of Bordetella pertussis with ciliated epithelial cells
David Jurnečka, Josef Chmelik, … Ladislav Bumba·bioRxiv·May 27, 2026
- Mucosal immunization with DTaP confers protection against Bordetella pertussis infection and cough in Sprague-Dawley rats
J. M. Hall, G. J. Bitzer, … F. H. Damron·bioRxiv·Jun 21, 2021
- Opposing effects of acellular and whole cell pertussis vaccines on Bordetella pertussis biofilm formation, Siglec-F+ neutrophil recruitment and bacterial clearance in mouse nasal tissues
J. M. Hall, J. L. Gutierrez-Ferman, … P. Dubey·bioRxiv·Jan 23, 2024
- Bps polysaccharide of Bordetella pertussis resists antimicrobial peptides by functioning as a dual surface shield and decoy and converts Escherichia coli into a respiratory pathogen.
A. R. Fullen, J. L. Gutierrez-Ferman, … R. Deora·bioRxiv·Apr 6, 2022